GCP
AMGN icon

Garda Capital Partners’s Amgen AMGN Stock Holding History

Garda Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,700
Closed -$475K – 52
2025
Q2 		$475K Hold
1,700
– – 0.01% 466
2025
Q1 		$530K Buy
+1,700
New +$502K 0.01% 532
2023
Q1 		– Sell
-23,500
Closed -$6.17M – 360
2022
Q4 		$6.17M Buy
+23,500
New +$6.3M 0.34% 79

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Garda Capital Partners's AMGN Position: Q1 2023 in Review

Garda Capital Partners sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,968 shares — an estimated $517K sold.

Garda Capital Partners first reported a position in AMGN in Q4 2022 and held it in 1 quarter. The position peaked at $517K in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Garda Capital Partners reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Garda Capital Partners sold 1,968 Amgen shares in Q1 2023, an estimated $517K.
  • Garda Capital Partners first reported a position in Amgen in Q4 2022 and held it in 1 quarter.
  • Garda Capital Partners's Amgen position peaked at $517K in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Garda Capital Partners's 13F filing for Q1 2023, filed 10 May 2023.